Total Funding
36
12
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
278242
AbboMax, a biotechnology platform, is an antibody product and service provider.
- Yuan Zhou: Chief Scientific Officer
Kelly Zhou: Co-Founder and Chief Scientific Officer
About the Company
AbboMax specializes in immunohistochemistry (IHC) and in situ hybridization (ISH) products and assay development. It provides high-quality custom service and products focusing on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks, Tissue Microarray (TMA) and CRO services including
recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), scale-up process for pharmaceutical companies and CLIA lab. All the manufacturing activities are performed in our the Silicon Valley Core Facility located in San Jose, California.
Women Founded
